iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD model

Exploratory Score: 0.900 Price: $0.50 Parkinson's disease iPSC-derived dopaminergic neurons and astrocytes, hESC-derived cells Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting N/A in iPSC-derived dopaminergic neurons and astrocytes, hESC-derived cells. Primary outcome: rescue of dopaminergic neuron degeneration and axonal pruning

Description

This study investigated whether iPSC-derived astrocytes can serve as mitochondrial donors to rescue injured dopaminergic neurons in an in vitro Parkinson's disease model. The researchers generated dopaminergic neurons and astrocytes from human iPSCs and hESCs, then established an astroglial-neuronal co-culture system. They used rotenone exposure to create neuronal injury mimicking PD pathology. The study examined intercellular mitochondrial transfer using Mito-Tracker Green labeling and tracked the transfer using immunocytochemistry and FACS analysis. Key findings included that healthy iPSC-derived astrocytes spontaneously release functional mitochondria into culture media, these mitochondria are internalized by injured neurons via a phospho-p38 dependent pathway, and the transferred mitochondria can significantly reverse dopaminergic neurodegeneration and axonal pruning caused by rotenone exposure. When astrocytic conditioned media was depleted of mitochondria by ultrafiltration, the neuroprotective effects were abolished, confirming that mitochondrial transfer was responsible for the rescue effect.

TARGET GENE
N/A
MODEL SYSTEM
iPSC-derived dopaminergic neurons and astrocytes, hESC-derived cells
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
mitochondrial function, phospho-p38 signaling pathway
SOURCE
extracted_from_pmid_32345341
PRIMARY OUTCOME
rescue of dopaminergic neuron degeneration and axonal pruning

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

ResearchersindexParkinproteinDopaminergic NeurodegenerationmechanismMitochondriaentityDopamineentityAstrocytesentityProdromal Parkinson's DiseasediseaseParkinson's Disease SubtypesdiseaseParkinson's Disease Genetic VariantsdiseaseGut-First vs Brain-First Parkinson's Disease TrajediseaseParkinson's Disease Dementia (PDD)diseaseParkinson's DiseasediseasePARK19 (DNAJC6-Related Parkinson's Disease)diseaseNeurodegenerationdiseaseInvestment Landscape: Parkinson's Diseasedisease

Protocol

Co-culture system with rotenone-induced injury, mitochondrial tracking with Mito-Tracker Green, immunocytochemistry, FACS analysis, ultrafiltration of conditioned media to deplete mitochondria

Expected Outcomes

iPSC-derived astrocytes would release functional mitochondria that could be transferred to injured neurons and provide neuroprotective effects

Success Criteria

Significant reversal of dopaminergic neurodegeneration and axonal pruning, detection of astrocytic mitochondria in neurons, loss of protection when mitochondria depleted from conditioned media

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.